Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02035124
What this trial is testing

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Who this might be right for
Advanced Prostate Cancer
SCRI Development Innovations, LLC
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07490210
What this trial is testing

Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Fudan University 300
Large-scale testing (Phase 3)Study completedNCT00849082
What this trial is testing

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT03423979
What this trial is testing

Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter

Who this might be right for
Benign Prostatic HyperplasiaBenign Prostatic Hypertrophy
Urotronic Inc. 80
Not applicableStudy completedNCT04790968
What this trial is testing

Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

Who this might be right for
Prostatic NeoplasmsNeoplasm Metastasis
Norwegian University of Science and Technology 90
Not applicableUnknownNCT04803188
What this trial is testing

Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I

Who this might be right for
Prostate Cancer (Diagnosis)
University of Roma La Sapienza 710
Large-scale testing (Phase 3)Study completedNCT00699751
What this trial is testing

A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases

Who this might be right for
Hormone Refractory Prostate CancerBone Metastases
Bayer 921
Not applicableStudy completedNCT06379880
What this trial is testing

Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution

Who this might be right for
Prostatic NeoplasmsLung NeoplasmsBreast Neoplasms+1 more
Centre Paul Strauss 411
Testing effectiveness (Phase 2)Study completedNCT00541281
What this trial is testing

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Who this might be right for
Hormone Resistant Prostate CancerMetastatic Prostate Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150
Testing effectiveness (Phase 2)Study completedNCT01393730
What this trial is testing

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Mary-Ellen Taplin, MD 40
Large-scale testing (Phase 3)Ended earlyNCT00005073
What this trial is testing

Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 544
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT07264205
What this trial is testing

RT-310 Safety and Feasibility BPH Study

Who this might be right for
BPH (Benign Prostatic Hyperplasia)
Resurge Therapeutics Inc. 20
Not applicableStudy completedNCT05701007
What this trial is testing

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Metastatic Castration Resistant Prostate Cancer (mCRPC)
Pfizer 1,083
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Not applicableUnknownNCT02935816
What this trial is testing

Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques

Who this might be right for
Prostate Cancer
University College, London 130
Testing effectiveness (Phase 2)Study completedNCT01289067
What this trial is testing

Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca

Who this might be right for
Prostate Cancer
William K. Oh 13
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableStudy completedNCT02410044
What this trial is testing

Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer

Who this might be right for
Breast CancerProstate CancerBone Metastases
iOMEDICO AG 500
Testing effectiveness (Phase 2)Study completedNCT01588821
What this trial is testing

Cabozantinib in Advanced Solid Malignancies

Who this might be right for
Lung CancerSolid Tumor (Not Breast or Prostate Cancers)
Massachusetts General Hospital 37
Next Page